Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 1, 2009, Pages

  Pérez, Alejandra ^a   Ojeda, Paola ^a   Valenzuela, Ximena ^a,b   Ortega, Marcela ^a   Sánchez, Claudio ^a   Ojeda, Lorena ^a   Castro, Maite ^a   Cárcamo, Juan G ^a   Rauch, M Cecilia ^a   Concha, Ilona I ^a   Rivas, Coralia I ^c   Vera, Juan C ^c   Reyes, Alejandro M ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Glucose transport; GLUT1 transporter; Transporter inhibition

Indexed keywords

CYTOCHALASIN B; GLUCOSE TRANSPORTER 1; GOSSYPOL;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE TRANSPORT; CELL STRAIN HL 60; CHO CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; ERYTHROCYTE GHOST; FLUORESCENCE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS;

3-O-METHYLGLUCOSE; ANIMALS; ANTIGENS, CD; BINDING SITES; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CRICETULUS; CYTOCHALASIN B; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GOSSYPOL; HL-60 CELLS; HUMANS; KINETICS; MODELS, BIOLOGICAL; NIACINAMIDE; RECEPTOR, INSULIN; SPECTROMETRY, FLUORESCENCE; TRANSFECTION;

CRICETULUS GRISEUS; MAMMALIA;

EID: 67650083307     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00501.2008     Document Type: Article

References (59)

1. Afzal I, Cunningham P, Naftalin RJ. Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1. Biochem J 365: 707-719, 2002.
2. Basketter DA, Widdas WF. Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors. J Physiol 278: 389-401, 1978.
3. Baumgrass R, Weiwad M, Erdmann F, Liu JO, Wunderlich D, Grabley S, Fischer G. Reversible inhibition of calcineurin by the polyphenolic aldehyde gossypol. J Biol Chem 276: 47914-47921, 2001.
4. Benz CC, Keniry MA, Ford JM, Townsend AJ, Cox FW, Palayoor S, Matlin SA, Hait WN, Cowan KH. Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol Pharmacol 37: 840-847, 1990.
5. Birnbaum MJ, Haspel HC, Rosen OM. Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc Natl Acad Sci USA 83: 5784-5788, 1986.
6. Burgos C, Gerez de Burgos NM, Rovai LE, Blanco A. In vitro inhibition by gossypol of oxidoreductases from human tissues. Biochem Pharmacol 35: 801-804, 1986.
7. Carruthers A. ATP regulation of the human red cell sugar transporter. J Biol Chem 261: 11028-11037, 1986.
8. Carruthers A. Facilitated diffusion of glucose. Physiol Rev 70: 1135-1176, 1990.
9. Cloherty EK, Heard KS, Carruthers A. Human erythrocyte sugar transport is incompatible with available carrier models. Biochemistry 35: 10411-10421, 1996.
10. De Peyster A, Hyslop PA, Kuhn CE, Sauerheber RD. Membrane structural/functional perturbations induced by gossypol. Effects on membrane order, liposome permeability, and insulin-sensitive hexose transport. Biochem Pharmacol 35: 3293-3300, 1986.
11. Deves R, Krupka RM. Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier. Biochim Biophys Acta 510: 339-348, 1978.
12. Fukumoto H, Seino S, Imura H, Seino Y, Eddy RL, Fukushima Y, Byers MG, Shows TB, Bell GI. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci USA 85: 5434-5438, 1988.
13. Gilbert NE, O'Reilly JE, Chang CJ, Lin YC, Brueggemeier RW. Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci 57: 61-67, 1995.
14. Gomez MS, Piper RC, Hunsaker LA, Royer RE, Deck LM, Makler MT, Vander Jagt DL. Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum. Mol Biochem Parasitol 90: 235-246, 1997.
15. Gorga FR, Lienhard GE. Changes in the intrinsic fluorescence of the human erythrocyte monosaccharide transporter upon ligand binding. Biochemistry 21: 1905-1908, 1982.
16. Gu Y, Lin YC, Rikihisa Y. Inhibitory effect of gossypol on steroidogenic pathways in cultured bovine luteal cells. Biochem Biophys Res Commun 169: 455-461, 1990.
17. Haspel HC, Corin RE, Sonenberg M. Effect of gossypol on erythrocyte membrane function: specific inhibition of inorganic anion exchange and interaction with band 3. J Pharmacol Exp Ther 234: 575-583, 1985.
18. Heard KS, Fidyk N, Carruthers A. ATP-dependent substrate occlusion by the human erythrocyte sugar transporter. Biochemistry 39: 3005-3014, 2000.
19. Honkanen R, McBath H, Kushmerick C, Callender G, Scarlata S, Fenstermacher J, Haspel H. Barbiturates inhibit hexose transport in cultured mammalian cells and human erythrocytes and interact directly with purified GLUT-1. Biochemistry 34: 535-544, 1995.
20. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol Membr Biol 18: 247-256, 2001.
21. Kasahara M, Hinkle PC. Reconstitution and purification of the D-glucose transporter from human erythrocytes. J Biol Chem 252: 7384-7390, 1977.
22. Kashiwagi A, Huecksteadt TP, Foley JE. The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes. J Biol Chem 258: 13685-13692, 1983.
23. Kirkin V, Joos S, Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644: 229-249, 2004.
24. Kitada S, Leone M, Sareth S, Zhai D, Reed J, Pellecchia M. Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 46: 4259-4264, 2003.
25. Lacko L, Wittke B, Geck P. Interaction of steroids with the transport system of glucose in human erythrocytes. J Cell Physiol 86, Suppl 2: 673-680, 1975.
26. Lacko L, Wittke B, Zimmer G. Interaction of benzoic acid derivatives with the transport system of glucose in human erythrocytes. Biochem Pharmacol 30: 1425-1431, 1981.
27. Lavis VR, Lee DP, Shenolikar S. Evidence that forskolin binds to the glucose transporter of human erythrocytes. J Biol Chem 262: 14571-14575, 1987.
28. Le Blanc M, Russo J, Kudelka AP, Smith JA. An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines. Pharmacol Res 46: 551-555, 2002.
29. LeFevre PG, Marshall JK. The attachment of phloretin and analogues to human erythrocytes in connection with inhibition of sugar transport. J Biol Chem 234: 3022-3026, 1959.
30. Lin TS, Schinazi R, Griffith BP, August EM, Eriksson BF, Zheng DK, Huang LA, Prusoff WH. Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypol. Antimicrob Agents Chemother 33: 2149-2151, 1989.
31. Mayr GW, Windhorst S, Hillemeier K. Antiproliferative plant and synthetic polyphenolics are specific inhibitors of vertebrate inositol 1,4,5-trisphosphate 3-kinases and inositol polyphosphate multikinase. J Biol Chem 280: 13229-13240, 2005.
32. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer.
33. Mohammad RM, Wang S, Aboukameel A, Chen B, Wu X, Chen J, Al-Katib A. Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL [(-)-gossypol] against diffuse large cell lymphoma. Mol Cancer Ther 4: 13-21, 2005.
34. Montamat EE, Burgos C, Gerez de Burgos NM, Rovai LE, Blanco A, Segura EL. Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi. Science 218: 288-289, 1982.
35. Naftalin R. Alternating carrier models of asymmetric glucose transport violate the energy conservation laws. Biophys J 95: 4300-4314, 2008.
36. Nakamura M, Ikeda M, Okinaga S, Arai K. Metabolism of round spermatids in the rat: effect of gossypol on the glucose transport. Andrologia 20: 411-416, 1988.
37. Pawagi AB, Deber CM. Ligand-dependent quenching of tryptophan fluorescence in human erythrocyte hexose transport protein. Biochemistry 29: 950-955, 1990.
38. Poso H, Wichmann K, Janne J, Luukkainen T. Gossypol, a powerful inhibitor of human spermatozoal metabolism. Lancet 1: 885-886, 1980.
39. Reed J. Bcl-2 family proteins: regulators of chemoresistance in cancer. Toxicol Lett 82-83: 155-158, 1995.
40. Reed J. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 7: 541-546, 1995.
41. Reyes AM, Bustamante F, Rivas CI, Ortega M, Donnet C, Rossi JP, Fischbarg J, Vera JC. Nicotinamide is not a substrate of the facilitative hexose transporter GLUT1. Biochemistry 41: 8075-8081, 2002.
42. Reyes J, Allen J, Tanphaichitr N, Bellve AR, Benos DJ. Molecular mechanisms of gossypol action on lipid membranes. J Biol Chem 259: 9607-9615, 1984.
43. Reyes J, Borriero L, Tanphaichitr N, Bellve AR, Benos DJ. Energy metabolism of cultured TM4 cells and the action of gossypol. Biol Reprod 34: 809-819, 1986.
44. Russell DH, Buckley AR, Montgomery DW, Larson NA, Gout PW, Beer CT, Putnam CW, Zukoski CF, Kibler R. Prolactin-dependent mitogenesis in Nb 2 node lymphoma cells: effects of immunosuppressive cyclopeptides. J Immunol 138: 276-284, 1987.
45. Salas-Burgos A, Iserovich P, Zuniga F, Vera JC, Fischbarg J. Predicting the three-dimensional structure of the human facilitative glucose transporter GLUT1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules. Biophys J 87: 2990-2999, 2004.
46. Sen AK, Widdas WF. Determination of the temperature and pH dependence of glucose transfer across the human erythrocyte membrane measured by glucose exit. J Physiol 160: 392-403, 1962.
47. Stephens DT, Critchlow LM, Hoskins DD. Mechanism of inhibition by gossypol of glycolysis and motility of monkey spermatozoa in vitro. J Reprod Fertil 69: 447-452, 1983.
48. Stephenson KN, Croxen RL, El Barbary A, Fenstermacher JD, Haspel HC. Inhibition of glucose transport and direct interactions with type 1 facilitative glucose transporter (GLUT-1) by etomidate, ketamine, and propofol: a comparison with barbiturates. Biochem Pharmacol 60: 651-659, 2000.
49. Van Poznak C, Seidman AD, Reidenberg MM, Moasser MM, Sklarin N, Van Zee K, Borgen P, Gollub M, Bacotti D, Yao TJ, Bloch R, Ligueros M, Sonenberg M, Norton L, Hudis C. Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. Breast Cancer Res Treat 66: 239-248, 2001.
50. Vera JC, Reyes AM, Carcamo JG, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Iribarren R, Scher HI, Slebe JC. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1. J Biol Chem 271: 8719-8724, 1996.
51. Vera JC, Reyes AM, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Slebe JC, Nunez-Alarcon J, Golde DW. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry 40: 777-790, 2001.
52. Vera JC, Rivas CI, Velasquez FV, Zhang RH, Concha II, Golde DW. Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J Biol Chem 270: 23706-23712, 1995.
53. Vera JC, Rivas CI, Zhang RH, Farber CM, Golde DW. Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid. Blood 84: 1628-1634, 1994.
54. Wu D. An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease. Drugs 38: 333-341, 1989.
55. Wu YW, Chik CL, Knazek RA. An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. Cancer Res 49: 3754-3758, 1989.
56. Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer. Mol Cancer Ther 4: 197-205, 2005.
57. Yu BZ, Rogers J, Ranadive G, Baker S, Wilton DC, Apitz-Castro R, Jain MK. Gossypol modification of Ala-1 of secreted phospholipase A2: a probe for the kinetic effects of sulfate glycoconjugates. Biochemistry 36: 12400-12411, 1997.
58. Zhang M, Liu H, Guo R, Ling Y, Wu X, Li B, Roller P, Wang S, Yang D. Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol 66: 93-103, 2003.
59. Zhang M, Liu H, Guo R, Ling Y, Wu X, Li B, Roller PP, Wang S, Yang D. Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol 66: 93-103, 2003.